HH - Supply of Patient-Specific Cytotoxic and Adjuvant Products (PSCAP)
- The Hillingdon Hospitals NHS Foundation Trust
- London
- Open procedure
- 1 July 2026 to 30 June 2029
Supply of patient-specific cytotoxic and adjuvant pharmaceutical products to the hospital pharmacy department. The contract involves the delivery of specialised medicinal products tailored to individual patient requirements, ensuring clinical safety and compliance with pharmaceutical standards for hospital-based oncology and adjuvant therapy services.
- Awarded value
- £9.3m
- As published
- Published
- 13 November 2025
- Contract length
- 36 months
- Ends 30 June 2029